Potential markers of insulin resistance in healthy VS obese and overweight subjects

Biomedical Papers

Volumn 154, Issue 3, 2010, Pages 245-250

  Horakova, Dagmar ^a   Stejskal, David ^b   Pastucha, Dalibor ^a   Muchova, Lenka ^a   Janout, Vladimir ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Central Moravian Hospital   (Czech Republic)

Author keywords

A fabp; Adiponectin; Asp; Healthy subjects; Insulin resistance; Obese subjects; Oma; Quicki

Indexed keywords

EID: 78049285358     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2010.037     Document Type: Article

References (19)

1. Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
2. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
3. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79, 1987; 790-800.
4. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes Care 2002; 25(10):1891-2.
5. National Institutes of Health. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). Washington DC: US Govt. Printing Office 2001, NIH publ. no. 01-3670.
6. Svacina S, et al. The metabolic syndrome. Praha: Triton; 2006.
7. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23:57-63.
8. De Vito E, La Torre G, Langiano E, Berardi D, Ricciardi G. Overweight and obesity among secondary school children in Central Italy. Eur J Epidemiol 1999; 15: 649-654.
9. Malincikova J, Stejskal D, Hrebicek J. Serum leptin and leptin receptors in healthy prepubertal children: Relations to insulin resistance and lipid parameters, body mass index (BMI), tumor necrosis factor α (TNFα), heart fatty acid binding protein (hFABP), and IgG anticardiolipin (ACL-IgG). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2000; 143:51-57.
10. Gwozdziewiczova S, Lichnovska R, Ben Yahia R, Chlup R, Hrebicek J. TNF-α in the development of insulin resistance and other disorders in metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149:109-117.
11. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal 2004; 68: 975-981.
12. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002; 87:144-147.
13. Lee JM, Kim SR, Yoo SJ, Hong OK, Son HS, Chang SA. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res 2009; 37:1803-1812.
14. Zaletel J, Barlovic DP, Prezelj J. Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with type 2 diabetes. J Endocrinol Invest 2010; in press.
15. Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 2006; 36:621-625.
16. Llaverias G, Noe V, Penuelas S, Vazquez-Carrera M, Sanchez RM, Laguna JC, et al. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem Biophys Res Commun 2004; 318:265-274.
17. Ahren B, Havel PJ, Pacini G, Cianflone K. Acylation stimulating protein stimulates insulin secretion. Int J Obes Relat Metab Disord 2003; 27:1037-1043.
18. Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, et al. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond) 2006; 30:439-446.
19. Cianflone K, Lu H, Smith J, Yu W, Wang H. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol 2005; 62:567-572.